英国:血友病患者获得重组因子VIII。

Canadian HIV/AIDS policy & law review Pub Date : 2003-12-01

Jennifer Gold

{"title":"英国:血友病患者获得重组因子VIII。","authors":"Jennifer Gold","doi":"","DOIUrl":null,"url":null,"abstract":"On 17 July 2003, the England and Wales High Court granted a hemophiliac leave to appeal a decision to refuse to provide him with recombinant factor VIII, a treatment for hemophilia not derived from human blood. The applicant had been infected with HIV and hepatitis B, C, and G through tainted blood products.","PeriodicalId":83647,"journal":{"name":"Canadian HIV/AIDS policy & law review","volume":"8 3","pages":"62"},"PeriodicalIF":0.0000,"publicationDate":"2003-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"UK: Hemophiliac wins access to recombinant factor VIII.\",\"authors\":\"Jennifer Gold\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"On 17 July 2003, the England and Wales High Court granted a hemophiliac leave to appeal a decision to refuse to provide him with recombinant factor VIII, a treatment for hemophilia not derived from human blood. The applicant had been infected with HIV and hepatitis B, C, and G through tainted blood products.\",\"PeriodicalId\":83647,\"journal\":{\"name\":\"Canadian HIV/AIDS policy & law review\",\"volume\":\"8 3\",\"pages\":\"62\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian HIV/AIDS policy & law review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian HIV/AIDS policy & law review","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

2003年7月17日，英格兰和威尔士高等法院准许一名血友病患者对一项拒绝向他提供重组因子VIII的决定提出上诉，重组因子VIII是一种非从人类血液中提取的血友病治疗方法。申请人曾通过受污染的血液制品感染艾滋病毒和乙型、丙型和丙型肝炎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

UK: Hemophiliac wins access to recombinant factor VIII.

On 17 July 2003, the England and Wales High Court granted a hemophiliac leave to appeal a decision to refuse to provide him with recombinant factor VIII, a treatment for hemophilia not derived from human blood. The applicant had been infected with HIV and hepatitis B, C, and G through tainted blood products.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Canadian HIV/AIDS policy & law review

自引率

0.00%

发文量